Skip to Content
  • MyChart

    Log in to our secure, personalized website to manage your care (formerly myMDAnderson).

  • Request an Appointment

    If you are ready to make an appointment, select a button on the right. If you have questions about UT MD Anderson’s appointment process, our information page may be the best place to start.

    Appointment Information
    New Patients Current Patients Referring Physicians
  • Every Breakthrough
    Begins With You

    Gifts to UT MD Anderson’s historic philanthropic campaign help accelerate discovery, transform lives and bring hope to more patients than ever before.

    Learn more about Only Possible Here
    Donate Today only-possible-here-logo
The University of Texas MD Anderson Cancer Center
  • Clinical Trials
  • Locations
  • Careers
  • Contact Us
  • Our Doctors
    • Español
    • عربى
    • 中文
    • Türkçe
Clear
close
      MyChart
      Donate Today
      • Clinical Trials
      • Locations
      • Careers
      • Contact Us
        • Español
        • عربى
        • 中文
        • Türkçe
      • Request an Appointment
      • New Patients
      • Current Patients
      • Referring Physicians
      • Patients & Family
          • Becoming Our Patient Home
          • Why UT MD Anderson
          • Planning for Care
          • Getting to UT MD Anderson
          • While You're Here
          • International Center
          • Services and Amenities
          • Insurance & Billing
          • Second Opinion Appointments
          • Diagnosis & Treatment Home
          • Cancer Types
          • A New Diagnosis
          • Treatment Options
          • Care Centers & Clinics
          • Emotional & Physical Effects
          • Patient Support
          • Clinical Trials
          • Supporting a Loved One Home
          • Caregiver Roles & Challenges
          • Children and Teens
          • Taking Care of Yourself
          • Helping a UT MD Anderson Patient
          • Dealing with Loss
          • Life After Cancer Home
          • Follow-up Care After Cancer Treatment
          • Long-Term Effects of Cancer
          • Social & Emotional Impacts of Cancer
          • Legal & Financial Impacts of Cancer
          • Survivorship Week
        • Request an Appointment Current Patients

          Find information and resources for current and returning patients.

          Clinical Trials

          Learn about clinical trials at UT MD Anderson and search our database for open studies.

      • Prevention & Screening
          • Manage Your Risk Home
          • Tobacco Control
          • Diet
          • Body Weight
          • Physical Activity
          • Skin Safety
          • HPV
          • Hepatitis
          • Alcohol
          • Family History Home
          • Genetic Testing
          • Hereditary Cancer Syndromes
          • Genetic Counseling and Testing FAQs
          • Cancer Screenings Home
          • Mammograms & Breast Cancer Screening
          • Cervical Cancer Screening
          • Colorectal Cancer Screening
          • Endometrial Cancer Screening
          • Liver Cancer Screening
          • Lung Cancer Screening
          • Mobile Mammography
          • Ovarian Cancer Screening
          • Prostate Cancer Screening
          • Skin Cancer Screening
          • Women's Cancer Screening
          • Men's Cancer Screening
        • Cancer Prevention Center 

          The Lyda Hill Cancer Prevention Center provides cancer risk assessment, screening and diagnostic services.

      • Donors & Volunteers
          • Donate Home
          • Raise Money
          • Honor Loved Ones
          • Create Your Legacy
          • Endowments
          • Caring Fund
          • Matching Gifts
          • Foundation and Corporation Relations
          • Volunteer Home
          • Why Volunteer
          • On-Site Volunteers
          • Volunteer Endowment
          • Patient Experience
          • Teen Volunteer Leadership Program
          • Children's Cancer Hospital Councils
          • Other Ways to Help Home
          • Give Blood
          • Shop UT MD Anderson
          • Children's Art Project
          • Donate Goods or Services
          • Attend Events
          • Cord Blood Bank
          • Corporate Alliances Home
          • Current Alliances
        • Join the Campaign to End Cancer 

          Help us celebrate and fuel the groundbreaking innovations and transformative advancements that define UT MD Anderson.

      • For Physicians
          • Refer a Patient Home
          • Health Care Provider Resource Center
          • Referring Provider Team
          • Insurance Information
          • International Referrals
          • myMDAnderson for Physicians
          • Second Opinion Pathology
          • Clinical Trials Home
          • Clinical Tools & Resources Home
          • Clinical Calculators
          • Clinical Practice Algorithms
        • myMDAnderson for Physicians 

          Our personalized portal helps you refer your patients and communicate with their UT MD Anderson care team.

      • Research
          • Departments, Labs and Institutes Home
          • Departments and Divisions
          • Labs
          • Research Centers and Programs
          • Institutes
          • Specialized Programs of Research Excellence (SPORE) Grants
          • Research Areas Home
          • Basic Science
          • Translational Research
          • Clinical Research
          • Prevention & Personalized Risk Assessment
          • Research Resources Home
          • Excellence in Science
          • Core Facilities and Services
          • Conferences & Seminars
          • Why Research at UT MD Anderson
          • STRIDE
          • NCI-Designated Cancer Center
          • Data Resources
        • Clinical Trials 

          As part of our mission to eliminate cancer, UT MD Anderson researchers conduct hundreds of clinical trials to test new treatments for both common and rare cancers.

      • Education & Training
          • Degree-Granting Schools Home
          • School of Health Professions
          • MD Anderson UTHealth Houston Graduate School
          • Research Training Home
          • Early Career Pathway Programs
          • Predoctoral Training
          • Postdoctoral Training
          • Mentored Faculty Programs
          • Career Development
          • Clinical Training Home
          • Graduate Medical Education
          • Clinical Education for Non-Physicians
          • Nursing Education & Training
          • Continuing Education & Review Courses
          • Simulation Center
          • Continuing Education & Professional Development Home
          • Continuing Professional Education/Conferences
          • Administrative Internships & Fellowships
          • Cancer Survivorship Professional Education
          • Leadership Institute
          • Patient Home Visits
          • Education Resources Home
          • Alumni Relations
          • Education Design Services
          • Awards & Recognitions
          • Academic Mentoring Council
          • Why UT MD Anderson & Houston
          • Outreach Programs Home
          • Project ECHO
          • Observer Programs
          • Comparative Effectiveness Training (CERTaIN)
          • Faculty Speakers Bureau
        • Apply to SHP

          Choose from 12 allied health programs at School of Health Professions.

          Research Trainees

          View open postdoctoral and other research trainee positions.

          GME Fellowships

          Learn about our graduate medical education residency and fellowship opportunities.

      Uddalak Bharadwaj Image

      Uddalak Bharadwaj, Ph.D.

      Department of Infectious Diseases, Infection Control, and Employee Health, Division of Internal Medicine

      Present Title & Affiliation

      Primary Appointment

      Assistant Professor, Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX

      Instructor, Medicine, Baylor College of Medicine, Houston, TX

      Research Associate, Baylor College of Medicine, Houston, TX

      Post-Doctoral/ Research Associate, Baylor College of Medicine, Houston, TX

      Post-Doctoral Fellow, The University of Texas MD Anderson Cancer Center, Houston, TX

      Dual/Joint/Adjunct Appointment

      Assistant Professor, Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX

      Education & Training

      Degree-Granting Education

      2004Genetics, SGPGI, India, India, IN, Ph.D. in Immunogenetics
      1996Calcutta University, Kolkata, IN, M.S. in Biochemistry
      1994Calcutta University, Kolkata, IN, BS in Chem (Hons)

      Postgraduate Training

      2010-2011Research Associate, Drug Development, Cancer Biology, Baylor College of Medicine, Houston, Texas
      2003-2010Post-Doctoral/Research Associate, Cancer Biology, Cancer Immunotherapy, Baylor College of Medicine, Houston, Texas
      2002-2003Post-Doctoral Research, Cancer Biology, MD Anderson Cancer Center, Houston, Texas

      Experience & Service

      Faculty Academic Appointments

      Instructor, Medicine, Baylor College of Medicine, Houston, TX, 2011 - 2015

      Research Associate, Baylor College of Medicine, Houston, TX, 2010 - 2011

      Post-Doctoral/ Research Associate, Baylor College of Medicine, Houston, TX, 2003 - 2010

      Post-Doctoral Fellow, The University of Texas MD Anderson Cancer Center, Houston, TX, 2002 - 2003

      Honors & Awards

      2008Christine Noonan Award for Outstanding Research, Baylor College of Medicine
      20083rd Best Presentation (Post-Doc), Baylor College of Medicine
      2004 - 2007Molecular Surgeon Young Investigator Award, Baylor College of Medicine
      2002Merit Award, 13th International Histocompatibility Workshop and Congress

      Selected Presentations & Talks

      National Presentations

      1. 2015. Targeting STAT3 with an oral small molecule inhibitor to reverse chemotherapy and radiation resistance. Conference. Targeting STAT3 with an oral small molecule inhibitor to reverse chemotherapy and radiation resistance, US.
      2. 2014. Piperlongumine Blocks JAK2-STAT3 Pathway to inhibit Collagen -Induced Platelet Reactivity Independent of Reactive Oxygen Species. Conference. Piperlongumine Blocks JAK2-STAT3 Pathway to inhibit Collagen -Induced Platelet Reactivity Independent of Reactive Oxygen Species, US.
      3. 2009. Novel MSLN-Aph1A interaction induced Notch Activation in pancreatic cancer pathogenesis. Conference. Novel MSLN-Aph1A interaction induced Notch Activation in pancreatic cancer pathogenesis, US.
      4. 2009. Novel MSLN-Aph1A interaction induced Notch Activation in pancreatic cancer pathogenesis. Conference. Novel MSLN-Aph1A interaction induced Notch Activation in pancreatic cancer pathogenesis, US.
      5. 2008. Mesothelin Overexpression Promotes IL-6 production and autocrine signaling in enhancing Pancreatic Cancer cell Proliferation. Conference. Mesothelin Overexpression Promotes IL-6 production and autocrine signaling in enhancing Pancreatic Cancer cell Proliferation. Houston, TX, US.
      6. 2008. Mesothelin Activates Akt Signaling Pathway Which Leads To NF-B Activation And Resistance To TNF Induced Apoptosis In Pancreatic Cancer Cells. Conference. Mesothelin Activates Akt Signaling Pathway Which Leads To NF-B Activation And Resistance To TNF Induced Apoptosis In Pancreatic Cancer Cells. Huntington Beach, CA, US.
      7. 2008. Mesothelin Overexpression Promotes IL-6 production and autocrine signaling in enhancing Pancreatic Cancer cell Proliferation. Conference. Mesothelin Overexpression Promotes IL-6 production and autocrine signaling in enhancing Pancreatic Cancer cell Proliferation. Houston, TX, US.
      8. 2007. Mesothelin Activates Akt Signaling Pathway Which Leads To NF-B Activation And Resistance To TNF Induced Apoptosis In Pancreatic Cancer Cells. Conference. Mesothelin Activates Akt Signaling Pathway Which Leads To NF-B Activation And Resistance To TNF Induced Apoptosis In Pancreatic Cancer Cells, US.
      9. 2007. Mesothelin Activates Akt Signaling Pathway Which Leads To NF-B Activation And Resistance To TNF Induced Apoptosis In Pancreatic Cancer Cells. Conference. Mesothelin Activates Akt Signaling Pathway Which Leads To NF-B Activation And Resistance To TNF Induced Apoptosis In Pancreatic Cancer Cells. Houston, TX, US.
      10. 2007. Overexpression Of Mesothelin In Pancreatic Cancer Cells Promotes Tumor Cell Growth Via Activation Of The Transcription Factor Stat3. Conference. Overexpression Of Mesothelin In Pancreatic Cancer Cells Promotes Tumor Cell Growth Via Activation Of The Transcription Factor Stat3. Phoenix, AZ, US.
      11. 2006. Mesothelin induces inflammatory cytokine production and enhances pancreatic cancer migration and proliferation by activating the transcription factor Stat3. Conference. Mesothelin induces inflammatory cytokine production and enhances pancreatic cancer migration and proliferation by activating the transcription factor Stat3. Houston, TX, US.
      12. 2006. Overexpression Of Mesothelin In Pancreatic Cancer Cells Promotes Tumor Cell Growth Via Activation of The Transcription Factor Stat3. Conference. Overexpression Of Mesothelin In Pancreatic Cancer Cells Promotes Tumor Cell Growth Via Activation of The Transcription Factor Stat3, US.
      13. 2006. Overexpression Of Mesothelin In Pancreatic Cancer Cells Promotes Tumor Cell Growth Via Activation Of The Transcription Factor Stat3. Conference. Overexpression Of Mesothelin In Pancreatic Cancer Cells Promotes Tumor Cell Growth Via Activation Of The Transcription Factor Stat3. Houston, TX, US.
      14. 2006. overexpression of Mesothelin in pancreatic cancer is associated with enhanced cell adhesion, migration and invasion. Conference. overexpression of Mesothelin in pancreatic cancer is associated with enhanced cell adhesion, migration and invasion. San Diego, CA, US.
      15. 2005. Inhibition Of Dendritic Cell Differentiation And Activation By Pancreatic Cancer Cell Line BxPC3. Conference. Inhibition Of Dendritic Cell Differentiation And Activation By Pancreatic Cancer Cell Line BxPC3. Nashville, TN, US.
      16. 2004. Cyclophilin A Modulates Dendritic Cell Differentiation From Myeloblastic Cell KG-1. Conference. Cyclophilin A Modulates Dendritic Cell Differentiation From Myeloblastic Cell KG-1. Houston, TX, US.
      17. 2004. Suppression of dendritic cell differentiation and activation by human pancreatic cancer cell line BxPC-3. Conference. Suppression of dendritic cell differentiation and activation by human pancreatic cancer cell line BxPC-3. Houston, TX, US.
      18. 2004. Inhibition Of Dendritic Cell Differentiation And Activation By Pancreatic Cancer Cell Line bxPC3: The Role Of Interleukin-6 And Granulocyte Colony-Stimulating Factor. Conference. Inhibition Of Dendritic Cell Differentiation And Activation By Pancreatic Cancer Cell Line bxPC3: The Role Of Interleukin-6 And Granulocyte Colony-Stimulating Factor. Houston, TX, US.
      19. 2002. HV3 shared epitope and molecular mimicry in rheumatoid arthritis: a study from north India. Conference. HV3 shared epitope and molecular mimicry in rheumatoid arthritis: a study from north India. Seattle, WA, US.

      International Presentations

      1. 2001. HLA class II genes and rheumatoid arthritis: a study from Uttar Pradesh. Conference. HLA class II genes and rheumatoid arthritis: a study from Uttar Pradesh. New Delhi, IN.
      2. 2000. HLA class II antigen distribution in Three North Indian Population from Uttar Pradesh. Conference. HLA class II antigen distribution in Three North Indian Population from Uttar Pradesh. Hydrabad, IN.
      3. 2000. HLA DR/DQ interaction in Rheumatoid Arthritis. Conference. HLA DR/DQ interaction in Rheumatoid Arthritis. Nagpur, IN.
      4. 2000. Allele frequencies for 24 microsatellites in three endogamous populations of North India (U.P). Conference. Allele frequencies for 24 microsatellites in three endogamous populations of North India (U.P). Nagpur, IN.

      Formal Peers

      1. 2008. Mesothelin activates Akt signaling pathway which leads to NF-B activation and resistance to apoptosis and anoikis in pancreatic cancer cells. Invited. Houston, TX, US.
      2. 2005. Suppression Of Dendritic Cell Differentiation And Activation By Human Pancreatic Cancer Cell Line BxPC-3. Invited. Houston, TX, US.
      Read More
      Less

      Grant & Contract Support

      Title:C 188-9, a Stat1/3 inhibitor, to treat radioresistant H&N SCC xenografts
      Funding Source:AHNS
      Role:PI
      ID:Piolet Grant 313720 (41768-I)
      Title:GARP (BCM)-illumina-RNA-Seq-grant
      Funding Source:BCM
      Role:PI
      ID:GARP (BCM)-illumina-RNA-Seq-grant
      Title:Targeting Stat1 and Stat3 with a Dual-Acting Inhibitor to Reverse Radioresistance in Head and Neck Cancer
      Funding Source:NIH
      Role:Co-I
      ID:R21 191556

      Selected Publications

      Peer-Reviewed Articles

      1. García, JP, Wurster, ST, Albert, ND, Bharadwaj, U, Bhoda, K, Kulkarni, VK, Ntita, M, Carstens, PR, Burch-Eapen, M, López, DC, Lizaola, JF, Larsen, KE, Matula, LM, Moghaddam, SM, Wang, Y, Kontoyiannis, DP, Evans, S. Immunotherapy with nebulized pattern recognition receptor agonists restores severe immune paralysis and improves outcomes in mice with influenza-associated pulmonary aspergillosis. mBio 16(5), 2025. e-Pub 2025. PMID: 40197039.
      2. Kumar, PR, Wurster, ST, Bavisi, K, da Silva, TA, Hauser, P, Kinnitt, J, Albert, ND, Bharadwaj, U, Neelapu, SS, Kontoyiannis, DP. A novel lentiviral vector-based approach to generate chimeric antigen receptor T cells targeting Aspergillus fumigatus. mBio 15(4), 2024. e-Pub 2024. PMID: 38415653.
      3. Wurster, ST, Albert, ND, Bharadwaj, U, Kasembeli, MM, Tarrand, JJ, Daver, N, Kontoyiannis, DP. Blockade of the PD-1/PD-L1 Immune Checkpoint Pathway Improves Infection Outcomes and Enhances Fungicidal Host Defense in a Murine Model of Invasive Pulmonary Mucormycosis. Frontiers in immunology 13, 2022. e-Pub 2022. PMID: 35251033.

      Abstracts

      1. Yuan H, Houck K, Tian Y, Zhou Z, Bharadwaj U, Wu X, Tweardy DJ, Romo D, Fu X, Zhang J, Dong JF. Piperlongumine Blocks JAK2-STAT3 Pathway to Inhibit Collagen-induced Platelet Reactivity Independent of Reactive Oxygen Species. Blood 124(21), 2014. e-Pub 2014.
      2. Lewis K, Bharadwaj U, Eckols TK, Kolosov M, Kasembeli MM, Cho SN, Liu J, DeMayo FJ, Tweardy DJ. Signaling Transducer and Activator of Transcription (Stat)3 Signaling and Targeting for Treatment and Prevention of Non-small Cell Lung Cancer. Chest, 2014. e-Pub 2014.
      3. Bharadwaj U, Marin-Muller C, Li M, Chen C, Yao Q. Novel MSLN-Aph1A interaction induced Notch Activation in pancreatic cancer pathogenesis, 2009. e-Pub 2009.
      4. Lay MK, Bharadwaj U, Hong H, Neil FH, K Sastry QYJ, Atmar RL, Estes MK. Norwalk Virus do not replicate in human macrophages or dendritic cells from the peripheral blood of susceptible humans, 2009. e-Pub 2009.
      5. Lackey K, Zhang S, Marin-Muller C, Bharadwaj U, Li M, Chen C, Yao Q. Modulating immunosuppressive cytokine production in mesothelin-overexpressing pancreatic cancer cells by micro-RNA, 2009. e-Pub 2009.
      6. Lackey K, Zhang S, Marin-Muller C, Bharadwaj U, Li M, Chen C, Yao Q. Modulating immunosuppressive cytokine production in mesothelin-overexpressing pancreatic cancer cells by micro-RNA, 2009. e-Pub 2009.
      7. Marin-Muller C, Bharadwaj U, Li M, Chen C, Yao Q. The role of MIR-198 in the regulatory circuitry of mesothelin-overexpressing pancreatic cancer pathogenesis, 2009. e-Pub 2009.
      8. Marin-Muller C, Bharadwaj U, Li M, Chen C, Yao Q. The role of MIR-198 in the regulatory circuitry of mesothelin-overexpressing pancreatic cancer pathogenesis, 2009. e-Pub 2009.
      9. Bharadwaj U, Marin-muller C, Li M, Chen C, Yao Q. Novel MSLN-Aph 1A interaction induced Notch Activation in pancreatic cancer pathogenesis, 2009. e-Pub 2009.
      10. Li M, Zhang Y, Bharadwaj U, Zhai Q, Fisher WE, Brunicardi FC, Logsdon CD, Chen C, Yao Q. Sielncing of Zinc transporter Zip4 inhibits Pancreatic cancer Growth and Increases the survival of nude mice with pancreatic cancer xenografts, 2008. e-Pub 2008.
      11. Marin-Muller C, Bharadwaj U, Li M, Chen C, Yao Q. Meothelin-Overexpressing Pancreatic Cancer cell down-Regulate Mir-198 to facilitate cell Proliferation, Invasion and Migration, 2008. e-Pub 2008.
      12. Bharadwaj U, Marin-Muller C, Li M, Chen C, Yao Q. Mesothelin Overexpression Promotes IL-6 production and autocrine signaling in enhancing Pancreatic Cancer cell Proliferation, 2008. e-Pub 2008.
      13. Bharadwaj U, Li M, Chen C, Yao Q. Mesothelin Activiites AKt Signaling Pathway Which Leads To Cell NF-B Activation And Resistance To TNF Induced Apoptosis In Pancreatic Cancer Cells, 2008. e-Pub 2008.
      14. Wang H, Li M, Bharadwaj U, Mu H, Zhang S, Yao Q, Chen C. Non-coding XIST RNA is decreased in pancreatic cancer and retroviral gene delivery of XIST RNS gene inhibits opancreatic cancer growth in vitro and in Vivo, 2008. e-Pub 2008.
      15. Marin-Muller C, Bharadwaj U, Li M, Chen C, Yao Q. Meothelin-Overexpressing Pancreatic Cancer cells down-Regulate Mir-198 to facilitate cell Proliferation, Invasion and Migration, 2008. e-Pub 2008.
      16. Bharadwaj U, marin-Muller C, li M, Chen C, Yao Q. Mesothelin Overexpression Promotes IL-6 production and autocrine signaling in enhancing Pancreatic Cancer cell Proliferation, 2008. e-Pub 2008.
      17. Bharadwaj U, Li M, Chen C, Yao Q. Mesothelin Activities Akt Signaling Pathway Which Leads To NF-B Activation And Resistance To TNF Induced Apoptosis In Pancreatic Cancer Cells, 2007. e-Pub 2007.
      18. Lay MK, Guix S, Bharadwaj U, Yao Q, Atmar RL, Estes MK. Does Norwalk Virus replicate in human dendritic cells?, 2007. e-Pub 2007.
      19. Bharadwaj U, Li M, Chen C, Yao Q. Mesothelin Activates Akt Signaling Pathway Which Leads To NF-B Activation And Resistance To TNF Induced Apoptosis In Pancreatic Cancer Cells, 2007. e-Pub 2007.
      20. Lay MK, Bharadwaj U, Hong H, Neil FH, K Sastry QYJ, Atmar RL, Estes MK. Norwalk Virus do not replicate in human macrophages or dendritic cells from the peripheral blood of susceptible humans, 2007. e-Pub 2007.
      21. Bharadwaj U, Agarwal N, Li M, Chen C, Yao Q. Overexpression of Mesothelin in pancreatic cancer is associated with enhanced cell adhesion, migration and invasion, 2007. e-Pub 2007.
      22. Bharadwaj U, Li M, Chen C, Yao Q. Overexpression of Meso thelin In Pancreatic Cancer Cells Promotes Tumor Cell Growth Via Activation Of The Transcription Factor Stat3, 2007. e-Pub 2007.
      23. li M, Bharadwaj U, Zhang R, Zhang S, Mu H, Fisher WAE, Brunicardi FC, Chen C, Yao Q. Mesothelin is a malignant factor and therapeutic vaccine target for pancreatic cancer, 2007. e-Pub 2007.
      24. Agarwal N, Liebig C, Tuszynski GP, Bharadwaj U, Gupta N, Albo D. Role of Angiocidin in Gelatinase Expression and Tumor Cell Invasion in Colon Cancer, 2007. e-Pub 2007.
      25. Agarwal N, Liebig C, Tuszynski GP, Bharadwaj U, Albo D. Fibroblasts Upregulate Gelatinase Activity and Promote Tumor Cell Invasion in Colon Cancer through Angiocidin, 2007. e-Pub 2007.
      26. Agarwal N, Liebig C, Tuszynski GP, Bharadwaj U, Albo D. Role of angiocidin in gelatinase expression and tumor cell invasion in colon cancer, 2006. e-Pub 2006.
      27. Bharadwaj U, Li M, Chen C, Yao Q. Mesothelin induces inflammatory cytokine production and enhances pancreatic cancer migration and proliferation by activating the transcription factor STAT3, 2006. e-Pub 2006.
      28. Bharadwaj U, Li M, Chen C, Yao Q. Overexpression Of Mesothelin In Pancreatic Cancer Cells Promotes Tumor Cell Growth Via Activation Of The Transcription Factor Stat3, 2006. e-Pub 2006.
      29. Bharadwaj U, Li M, Chen C, Yao Q. Overexpression of Mesothelin In Pancreatic Cancer Cells Promotes Tumor Cell Growth Via Activation Of TheTranscription Factor Stat3, 2006. e-Pub 2006.
      30. Li M, Feurino L, Bharadwaj U, Zhang R, Li F, Chai H, Fisher WE, Brunicardi FC, Chen C, Yao Q. IL-6 promotes pancreatic cancer Growth by upregulating VEGF and neuropilins, and increasing TH2 cytokine secretion, 2006. e-Pub 2006.
      31. Agarwal N, Liebig C, Tuszynski GP, Bharadwaj U, Gupta N, Albo D. Role of Angiocidin in Gelatinase Expression and Tumor Cell Invasion in Colon Cancer, 2006. e-Pub 2006.
      32. Agrawal N, Liebig C, Tuszynski GP, Bharadwaj U, Albo D. Angiocidin, A Novel Thrombospondin-1 Receptor, and Matrix Gelatinases are Up-regulated in Colorectal Cancer, 2005. e-Pub 2005.
      33. Li M, Zhai Q, Bharadwaj U, Wang H, Yang H, Chai H, Li F, Fisher WE, Chen C, Yao Q. Cyclophilin A is overexpressed in human pancreatic cancer cells and stimulates cell proliferation through CD147, 2005. e-Pub 2005.
      34. Bharadwaj U, Li M, Zhang R, Lin XD, Chen C, Yao Q. Inhibition Of Dendritic Cell Differentiation And Activation By Pancratic Cancer Cell Line BxPC3, 2005. e-Pub 2005.
      35. Bharadwaj U, Li M, Zhang R, Yang H, Doan LX, Chen C, Yao Q. Cyclophilin A Modulates Dendritic Cell Differentiation From Myeloblastic Cell KG-1, 2004. e-Pub 2004.
      36. Bharadwaj U, Li M, Zhang R, Lin XD, Chen C, Yao Q. Suppression of dendritic cell differentiation and activation by human pancreatic cancer cell line BxPC-3, 2004. e-Pub 2004.
      37. Bharadwaj U, Li M, Zhang R, Lin XD, Chen C, Yao Q. Inhibition Of Dendritic Cell Differentiation And Activation By Pancreatic Cancer Cell Line BxPC3: The Role Of Interleukin-6 And Granulocyte Colony-Stimulating Factor, 2004. e-Pub 2004.
      38. Bharadwaj U, Mishra RN, Aggarwal A, Naik S, Agrawal S. HV3 shared epitope and molecular mimicry in rheumatoid arthritis: a study from north India, 2002. e-Pub 2002.
      39. Bharadwaj U, Mishra RN, Aggarwal A, Naik S, Agrawal S. HLA class II genes and rheumatoid arthritis: a study from Uttar Pradesh, 2001. e-Pub 2001.
      40. Sharma A, Bharadwaj U, Bhatnagar S, Khan F, Agarwal SS, Agrawal S. DNA short tandem repeat profiling of three north Indian populations, 2000. e-Pub 2000.
      41. Bharadwaj U, Bhatnagar S, Sharma A, Talwar S, Khan F, Agarwal SS, Agrawal S. HLA class II antigen distribution in Three North Indian population from Uttar Pradesh, 2000. e-Pub 2000.
      42. Khan F, Bharadwaj U, Sharma A, Bhatnagar S, Agarwal SS, Agrawal S. Analysis of Apolipoprotiein B Gene 3 Hypervariable Region among three North Indian population and comparison with other world population, 2000. e-Pub 2000.
      43. Bharadwaj U, Agrawal S, Bhatnagar S, Myhsok BM, Agarwal SS. Allele frequencies for 24 microsatellites in three endogamous populations of North India (U.P.), 2000. e-Pub 2000.
      44. Bharadwaj U, Mishra RN, Aggarwal A, Naik S, Agrawal S. HLA DR/DQ interaction in Rheumatoid Arthritis, 2000. e-Pub 2000.
      Read More
      Less

      Patient Reviews


      CV information above last modified July 22, 2026

      Request an Appointment

      Whether you are ready to make an appointment now or have questions for our expert team, we are standing by to help.
      Learn more

      Related Links

      • Care Centers and Clinics

      • Departments and Divisions

      • Labs

      Clinical Trials

      Our patients have access to clinical trials offering promising new treatments that cannot be found anywhere else.
      Learn more

      Help #EndCancer

      Give Now

      Your gift will help make a tremendous difference.
      Donate

      Donate Blood

      Our patients depend on blood and platelet donations.

      Make an appointment

      Shop UT MD Anderson

      Show your support for our mission through branded merchandise.

      View products
      Subscribe to our Cancerwise newsletter
      UT MD Anderson logoUT MD Anderson logo
      • Explore
      • Patients & Family
      • Prevention & Screening
      • Donors & Volunteers
      • For Physicians
      • Research
      • Education & Training
      • Clinical Trials
      • Languages
      • About
      • About UT MD Anderson
      • Careers
      • Blog
      • Newsroom
      • Editorial Standards
      • For Employees
      • Merchandise
      • Title IX Reporting (Sexual Misconduct)
      • Price Transparency
      • Finding Your Way
      • Our Doctors
      • Locations
      • Directions
      • Sitemap
      • DIGITAL ACCESSIBILITY
      • Accessibility Policy MD Anderson works with Level Access to ensure our website is accessible and functional for all users. Free assistive technology is provided for people with physical disabilities. To learn more or to download the assistive technology tool, visit https://www.levelaccess.com/MDAnderson
      • GET IN TOUCH
      • Call
        1-877-632-6789
      • Ask a question
      • Stay Connected
      • Cancerwise Podcast
      • More
      • Website Privacy Policy
      • Legal Statement & Policies
      • Reports to the State
      • Emergency Alert Information
      • State of Texas Links
      • Our Cancer Network
      • Vendors & Suppliers
      UT MD Anderson logo
      The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

      © 2026 The University of Texas MD Anderson Cancer Center. All rights reserved.

      Top